AlphaMark Advisors LLC Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

AlphaMark Advisors LLC purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 60 shares of the healthcare conglomerate’s stock, valued at approximately $30,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Kathleen S. Wright Associates Inc. purchased a new stake in UnitedHealth Group in the 3rd quarter worth approximately $27,000. Global Wealth Strategies & Associates boosted its position in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares during the last quarter. West Financial Advisors LLC acquired a new position in UnitedHealth Group in the 3rd quarter worth about $32,000. RPg Family Wealth Advisory LLC bought a new stake in shares of UnitedHealth Group in the 3rd quarter valued at approximately $37,000. Finally, Quarry LP raised its holdings in shares of UnitedHealth Group by 132.1% during the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 37 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the stock. TD Cowen boosted their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Stephens increased their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. Royal Bank of Canada dropped their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. Finally, KeyCorp reissued an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. One research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $627.74.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $532.26 on Monday. The firm has a 50 day simple moving average of $541.04 and a 200 day simple moving average of $564.34. The company has a market cap of $489.83 billion, a price-to-earnings ratio of 34.34, a PEG ratio of 1.41 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the prior year, the firm earned $5.83 EPS. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. Research analysts predict that UnitedHealth Group Incorporated will post 29.74 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.58%. UnitedHealth Group’s dividend payout ratio is 54.19%.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.